drugset / Trial / NCT01203371
Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the effectiveness and safety of Naftopidil and Tamsulosin in the treatment of lower urinary tract symptoms through a comparative study of patients with benign prostatic hyperplasia.
Timeline
- Start
- 2011-01-01
- Primary completion
- 2011-09-01
- Completion
- 2012-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naftopidil | Small molecule | 0.5 mg | — |
| Comparator | Tamsulosin | Other / unclassified | 0.4 mg | — |